Clinical Trial Update: A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating toripalimab alone or in combination with temozolomide for advanced/metastatic malignant melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Temozolomide (Temozolomide)
• Toripalimab (Toripalimab)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Malignant Melanoma | Phase 2 | Status: UNKNOWN